- Previous Close
0.1150 - Open
0.1050 - Bid 0.0960 x --
- Ask 0.1100 x --
- Day's Range
0.0950 - 0.1050 - 52 Week Range
0.0940 - 0.5900 - Volume
958,097 - Avg. Volume
575,619 - Market Cap (intraday)
55.197M - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.13
MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, a vaccination and clinical workflow recording solution; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Melbourne, Australia.
www.medadvisorsolutions.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: MDR.AX
View MorePerformance Overview: MDR.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDR.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDR.AX
View MoreValuation Measures
Market Cap
55.20M
Enterprise Value
61.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
0.98
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
41.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.51%
Return on Assets (ttm)
-1.35%
Return on Equity (ttm)
-8.34%
Revenue (ttm)
103.66M
Net Income Avi to Common (ttm)
-4.68M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
12.4M
Total Debt/Equity (mrq)
33.53%
Levered Free Cash Flow (ttm)
-10.08M